Freeline Therapeutics : Reports Second Quarter 2023 Financial Results and Business Highlights - Form 6-K -December 01, 2023 at 08:59 am EST
Freeline Reports Second Quarter 2023 Financial Results and Business Highlights Completed dosing in first cohort of Phase 1/2 GALILEO-1 trial of FLT201 in Gaucher disease; expect...
Source: marketscreener.com